Table 2 Patient’s clinical characteristics.
From: Sleep hygiene in patients with early-stage breast cancer: a short report
Number | 315 | Number | 315 |
|---|---|---|---|
Stage of breast cancer(%) | Currently taking steroids (%) | ||
Stage 1 | 57 (18.1) | Yes | 29 (9.2) |
Stage 2 | 93 (29.5) | No | 271 (86.0) |
Stage 3 | 46 (14.6) | Unanswered | 15 (4.8) |
Stage 4 | 36 (11.4) | ||
Unknown | 83(26.4) | ||
Given advice on what time of day to take steroids(%) | |||
First diagnosed with breast cancer (%) | Yes | 20 (6.3) | |
<6 months | 48 (15.2) | No | 6 (1.9) |
6 months – 1 year | 51 (16.2) | Unsure | 3 (1.0) |
1 year – 3 years | 79 (25.1) | Not currently taking steroids | 286 (90.8) |
3 years – 5 years | 44 (14.0) | ||
5 years+ | 90 (28.6) | Currently taking sleeping tablets (%) | |
Unanswered | 3 (1.0) | Yes | 40 (12.7) |
No | 266 (84.4) | ||
Surgery for breast cancer (%) | Unanswered | 9 (2.8) | |
Yes | 294 (93.3) | ||
No | 18 (5.7) | Currently taking relaxants/anxiolytics (%) | |
Unsure | 3 (1.0) | Yes | 43 (13.7) |
No | 262 (83.2) | ||
Chemotherapy (%) | Unanswered | 10 (3.1) | |
Currently receiving | 57 (18.1) | ||
Planned | 4 (1.3) | Currently taking hormonal treatment (%) | |
Never/not planned | 94 (29.8) | Yes | 184 (58.4) |
Received in the past | 143 (45.4) | No | 113 (35.9) |
Unanswered | 17 (5.4) | Unsure/unanswered | 18 (5.7) |
Type of hormonal treatment (%) | |||
Time since chemotherapy(%) | Tablets | 167 (90.8) | |
< 1 year | 24 (7.6) | Injections | 38 (20.7) |
1–3 years | 38 (12.1) | Other/unsure | 10 (5.4) |
3–5 years | 22 (7.0) | Total | 184 (100) |
5 years+ | 60 (19.0) | ||
Not applicable | 171 (54.3) | Name of hormonal treatmenta | |
Anastrozole | 47 (25.5) | ||
Radiotherapy(%) | Anastrozole + Zoladex | 4 (2.2) | |
Currently receiving | 3 (1.0) | Exemestane | 14 (7.6) |
Planned | 31 (9.8) | Exemestane + Zoladex | 4 (2.2) |
Never/Not planned | 26 (8.3) | Faslodex | 4 (2.2) |
Received in the past | 241 (76.5) | Letrozole | 14 (7.6) |
Unanswered | 14 (4.4) | Letrozole + Zoladex | 6 (3.3) |
Tamoxifen | 32 (17.4) | ||
Time since radiotherapy | Tamoxifen + Zoladex | 2 (1.1) | |
< 1 year | 54 (17.2) | Zoladex | 5 (2.7) |
1–3 years | 63 (20.0) | Other | 52 (28.2) |
3–5 years | 40 (12.7) | Total | 184 (100) |
5 years+ | 81 (25.7) | ||
Not applicable | 77 (24.4) | ||
